康希诺：自愿披露关于吸入用肺结核疫苗（5型腺病毒载体）于印度尼西亚启动Ⅰ期临床试验并完成首例受试者入组的公告

Core Points - The company announced the initiation of Phase I clinical trials for its inhaled tuberculosis vaccine in Indonesia [2] - The first subject has been enrolled in the Phase I clinical trial [2] Company Summary - 康希诺生物股份公司 is developing an inhaled tuberculosis vaccine using a 5-type adenoviral vector [2] - The vaccine is referred to as "inhaled tuberculosis booster vaccine" [2]